Slideshow
Author(s):
Eighteen percent of all improperly used thrombolytic treatments in the emergency department occur in patients with migraine with aura.
NeurologyLive® Friday 5 — February 7, 2024
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Sleeping Around the Podcast × NeurologyLive: Calcitonin Gene-Related Peptide in Sleep Research
Fascia Exercises May Serve as Effective, Novel Therapy for Migraine Management
Updates in Therapeutic Development: Clinical Trial Readouts to Watch in the First Half of 2025